STANDARD BIOTOOLS INC. Operating Income Loss

• STANDARD BIOTOOLS INC. showed an increase of +13.5% in Operating Income Loss from 2024 to 2025.
• This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), STANDARD BIOTOOLS INC.'s Operating Income Loss has declined by 511.2%.
• Historical annual values: Fiscal year 2025: -$110.25 million | Fiscal year 2024: -$127.49 million | Fiscal year 2023: -$76.60 million | Fiscal year 2022: -$116.21 million | Fiscal year 2021: -$67.46 million | Fiscal year 2020: -$51.04 million | Fiscal year 2019: -$51.84 million | Fiscal year 2018: -$48.16 million | Fiscal year 2017: -$58.36 million | Fiscal year 2016: -$73.19 million | Fiscal year 2015: -$50.16 million | Fiscal year 2014: -$51.84 million | Fiscal year 2013: -$18.65 million | Fiscal year 2012: -$18.07 million | Fiscal year 2011: -$18.57 million | Fiscal year 2010: -$14.57 million | Fiscal year 2009: -$18.04 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026